crypto to currency, snippets

Analysis and interpretation of securities, semiconductors, medicine and gold technology!3. With the gradual relaxation of the US Biosafety Law on innovative drugs on our side, the recent pharmaceutical sector has obviously picked up, which has promoted a rebound to varying degrees. However, before the fundamentals improve, it is really not easy to really strengthen.4. As the expectations of the European Central Bank and the Federal Reserve to cut interest rates in December are getting closer and closer, some prophetic funds began to flow back to the gold plate. In addition, in order to cope with various uncertainties, major central banks gradually regard gold as a diversified choice of strategic reserves, which is conducive to providing support for gold prices.

Analysis and interpretation of securities, semiconductors, medicine and gold technology!3. With the gradual relaxation of the US Biosafety Law on innovative drugs on our side, the recent pharmaceutical sector has obviously picked up, which has promoted a rebound to varying degrees. However, before the fundamentals improve, it is really not easy to really strengthen.1. After yesterday's large-scale surge, the sentiment of long capital was obviously affected, and the trading volume of the two cities also shrank significantly, which led to the shock consolidation of today's securities sector around the 5-day moving average. Whether it can strengthen again next depends on when the expectation of interest rate cuts and RRR cuts in December will land.

Analysis and interpretation of securities, semiconductors, medicine and gold technology!4. As the expectations of the European Central Bank and the Federal Reserve to cut interest rates in December are getting closer and closer, some prophetic funds began to flow back to the gold plate. In addition, in order to cope with various uncertainties, major central banks gradually regard gold as a diversified choice of strategic reserves, which is conducive to providing support for gold prices.3. With the gradual relaxation of the US Biosafety Law on innovative drugs on our side, the recent pharmaceutical sector has obviously picked up, which has promoted a rebound to varying degrees. However, before the fundamentals improve, it is really not easy to really strengthen.